Zomedica Announced The Issuance Of Three New Patents Bolstering The Intellectual Property Protection For Its Revolutionary TRUFORMA Diagnostic Platform

Zomedica Announced The Issuance Of Three New Patents Bolstering The Intellectual Property Protection For Its Revolutionary TRUFORMA Diagnostic Platform

BenzingaMay 2 18:41

Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 P.m. ET

ANN ARBOR, MI / ACCESSWIRE / April 30, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products f

AccesswireApr 30 18:30

Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024

ANN ARBOR, MI / ACCESSWIRE / April 9, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic device prod

AccesswireApr 9 18:30

Zomedica Corp. (AMEX:ZOM) Q4 2023 Earnings Call Transcript

Yahoo FinanceApr 2 23:36

Earnings Call Summary | Zomedica(ZOM.US) Q4 2023 Earnings Conference

The following is a summary of the Zomedica Corp. (ZOM) Q4 2023 Earnings Call Transcript:Financial Performance:Zomedica reported a record Q4 revenue of $7.3 million, signifying a 19% growth YoY and ful

Futu NewsApr 2 09:50 · Conference Call

Zomedica Q4 2023 GAAP EPS $(0.02), Sales $7.337M Beat $7.000M Estimate

Zomedica (AMEX:ZOM) reported quarterly losses of $(0.02) per share. The company reported quarterly sales of $7.337 million which beat the analyst consensus estimate of $7.000 million by 4.81 percent.

BenzingaApr 2 04:28